China Biotech Week in Review: China Track at J.P. Morgan Conference
ChinaBio Today submits: For the first time in its 29 years, the J.P. Morgan Healthcare Conference, which will take place in San Francisco next week, will include a track focused specifically on China (see story). On Wednesday, January 12, fourteen China-based life science companies will present their plans to interested investors. The special track gives implicit recognition by this important US conference that China has become a critical part of international biopharma. Shanxi Zhendong Pharma (SZ: 300158) completed its IPO on the ChiNext Exchange on Friday, issuing 36 million shares at 38.8 RMB per share ($5.85) (see story). The company raised 1.4 billion RMB ($211 million) in the offering at a price/earnings ratio of 82.6. In its first day of trading, the stock moved only modestly higher, closing at 39.03 RMB. Complete Story »
- Original article
- Login or register to post comments
